267 related articles for article (PubMed ID: 28590590)
1. Repurposing of Human Kinase Inhibitors in Neglected Protozoan Diseases.
Dichiara M; Marrazzo A; Prezzavento O; Collina S; Rescifina A; Amata E
ChemMedChem; 2017 Aug; 12(16):1235-1253. PubMed ID: 28590590
[TBL] [Abstract][Full Text] [Related]
2. Neglected Tropical Protozoan Diseases: Drug Repositioning as a Rational Option.
Sbaraglini ML; Vanrell MC; Bellera CL; Benaim G; Carrillo C; Talevi A; Romano PS
Curr Top Med Chem; 2016; 16(19):2201-22. PubMed ID: 26881713
[TBL] [Abstract][Full Text] [Related]
3. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part I.
Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
Curr Med Chem; 2012; 19(14):2128-75. PubMed ID: 22414103
[TBL] [Abstract][Full Text] [Related]
4. The potential of secondary metabolites from plants as drugs or leads against protozoan neglected diseases - part II.
Schmidt TJ; Khalid SA; Romanha AJ; Alves TM; Biavatti MW; Brun R; Da Costa FB; de Castro SL; Ferreira VF; de Lacerda MV; Lago JH; Leon LL; Lopes NP; das Neves Amorim RC; Niehues M; Ogungbe IV; Pohlit AM; Scotti MT; Setzer WN; de N C Soeiro M; Steindel M; Tempone AG
Curr Med Chem; 2012; 19(14):2176-228. PubMed ID: 22414104
[TBL] [Abstract][Full Text] [Related]
5. Drug Repurposing and De Novo Drug Discovery of Protein Kinase Inhibitors as New Drugs against Schistosomiasis.
Pereira Moreira B; Weber MHW; Haeberlein S; Mokosch AS; Spengler B; Grevelding CG; Falcone FH
Molecules; 2022 Feb; 27(4):. PubMed ID: 35209202
[TBL] [Abstract][Full Text] [Related]
6. Antiprotozoal Activity Profiling of Approved Drugs: A Starting Point toward Drug Repositioning.
Kaiser M; Mäser P; Tadoori LP; Ioset JR; Brun R
PLoS One; 2015; 10(8):e0135556. PubMed ID: 26270335
[TBL] [Abstract][Full Text] [Related]
7. Screening Marine Natural Products for New Drug Leads against Trypanosomatids and Malaria.
Álvarez-Bardón M; Pérez-Pertejo Y; Ordóñez C; Sepúlveda-Crespo D; Carballeira NM; Tekwani BL; Murugesan S; Martinez-Valladares M; García-Estrada C; Reguera RM; Balaña-Fouce R
Mar Drugs; 2020 Mar; 18(4):. PubMed ID: 32244488
[TBL] [Abstract][Full Text] [Related]
8. Small molecules containing chalcogen elements (S, Se, Te) as new warhead to fight neglected tropical diseases.
Henriquez-Figuereo A; Morán-Serradilla C; Angulo-Elizari E; Sanmartín C; Plano D
Eur J Med Chem; 2023 Jan; 246():115002. PubMed ID: 36493616
[TBL] [Abstract][Full Text] [Related]
9. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
[TBL] [Abstract][Full Text] [Related]
10. Vaccines to combat the neglected tropical diseases.
Bethony JM; Cole RN; Guo X; Kamhawi S; Lightowlers MW; Loukas A; Petri W; Reed S; Valenzuela JG; Hotez PJ
Immunol Rev; 2011 Jan; 239(1):237-70. PubMed ID: 21198676
[TBL] [Abstract][Full Text] [Related]
11. Repurposing strategies for tropical disease drug discovery.
Klug DM; Gelb MH; Pollastri MP
Bioorg Med Chem Lett; 2016 Jun; 26(11):2569-76. PubMed ID: 27080183
[TBL] [Abstract][Full Text] [Related]
12. Marine alkaloids as bioactive agents against protozoal neglected tropical diseases and malaria.
Tempone AG; Pieper P; Borborema SET; Thevenard F; Lago JHG; Croft SL; Anderson EA
Nat Prod Rep; 2021 Dec; 38(12):2214-2235. PubMed ID: 34913053
[TBL] [Abstract][Full Text] [Related]
13. Repurposing as a strategy for the discovery of new anti-leishmanials: the-state-of-the-art.
Charlton RL; Rossi-Bergmann B; Denny PW; Steel PG
Parasitology; 2018 Feb; 145(2):219-236. PubMed ID: 28805165
[TBL] [Abstract][Full Text] [Related]
14. Metallodrugs for the Treatment of Trypanosomatid Diseases: Recent Advances and New Insights.
Navarro M; Justo RMS; Delgado GYS; Visbal G
Curr Pharm Des; 2021; 27(15):1763-1789. PubMed ID: 33185155
[TBL] [Abstract][Full Text] [Related]
15. Drug repurposing for parasitic protozoan diseases.
Vijayasurya ; Gupta S; Shah S; Pappachan A
Prog Mol Biol Transl Sci; 2024; 207():23-58. PubMed ID: 38942539
[TBL] [Abstract][Full Text] [Related]
16. Designing selective inhibitors for calcium-dependent protein kinases in apicomplexans.
Hui R; El Bakkouri M; Sibley LD
Trends Pharmacol Sci; 2015 Jul; 36(7):452-60. PubMed ID: 26002073
[TBL] [Abstract][Full Text] [Related]
17. Transition-state-guided drug design for treatment of parasitic neglected tropical diseases.
Murkin AS; Moynihan MM
Curr Med Chem; 2014; 21(15):1781-93. PubMed ID: 24083604
[TBL] [Abstract][Full Text] [Related]
18. The Potential of Secondary Metabolites from Plants as Drugs or Leads against Protozoan Neglected Diseases-Part III: In-Silico Molecular Docking Investigations.
Ogungbe IV; Setzer WN
Molecules; 2016 Oct; 21(10):. PubMed ID: 27775577
[TBL] [Abstract][Full Text] [Related]
19. In silico repositioning of approved drugs for rare and neglected diseases.
Ekins S; Williams AJ; Krasowski MD; Freundlich JS
Drug Discov Today; 2011 Apr; 16(7-8):298-310. PubMed ID: 21376136
[TBL] [Abstract][Full Text] [Related]
20. Approaches to protozoan drug discovery: phenotypic screening.
Sykes ML; Avery VM
J Med Chem; 2013 Oct; 56(20):7727-40. PubMed ID: 23927763
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
